Travere Therapeutics (TVTX) Q4 2024 Earnings

31OctConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.76
-1.4
-1.03
-0.67

Details

Expected EPS
-0.669135
Actual EPS
-0.7
Surprise EPS
-0.03
Surprise Percent
+4.61%

Description

Travere Therapeutics (TVTX) has reported earnings of -0.7 per share for Q4 2024.

0 Comments

Share your thoughts